Cargando…
Modulation of the Immune System for the Treatment of Glaucoma
BACKGROUND: At present intraocular pressure (IOP) lowering therapies are the only approach to treat glaucoma. Neuroprotective strategies to protect the retinal ganglion cells (RGC) from apoptosis are lacking to date. Substantial amount of research concerning the role of the immune system in glaucoma...
Autores principales: | Bell, Katharina, von Thun, Nadine, Teister, Julia, Grus, Franz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120111/ https://www.ncbi.nlm.nih.gov/pubmed/28730968 http://dx.doi.org/10.2174/1570159X15666170720094529 |
Ejemplares similares
-
Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma
por: Gramlich, Oliver W., et al.
Publicado: (2016) -
Intravitreal injection of β-crystallin B2 improves retinal ganglion cell survival in an experimental animal model of glaucoma
por: Anders, Fabian, et al.
Publicado: (2017) -
Decelerated neurodegeneration after intravitreal injection of α-synuclein antibodies in a glaucoma animal model
por: Teister, J., et al.
Publicado: (2017) -
Glaucoma related Proteomic Alterations in Human Retina Samples
por: Funke, Sebastian, et al.
Publicado: (2016) -
The Small Heat Shock Protein α-Crystallin B Shows Neuroprotective Properties in a Glaucoma Animal Model
por: Anders, Fabian, et al.
Publicado: (2017)